Advances in Pharmacoepidemiology and Drug Safety

Mar�a Victoria Hern�ndez

Biography

Dr. María Victoria Hernández has received her MD and her PhD in the University of Barcelona in 2003. Currently, she is working as a Consultant in Rheumatology in the Arthritis Unit at the Rheumatology Department in Hospital Clinic of Barcelona. She is also an Assistant Professor of the Rheumatology Department at University of Barcelona and a Professor of the International Master in Autoimmune Diseases at the University of Barcelona Her research has included, among other topics, the safety and efficacy of biological therapies in patients with rheumatic inflammatory conditions, and also in patients with non-infectious uveitis. She has also conducted several clinical trials in patients with rheumatoid arthritis and spondyloarthritis. Based on this research and fellowship training he has received several awards and honors, such as the 'Best paper award in Epidemiology in Rheumatic Diseases' from the Spanish Society of Rheumatology, and the 'Best paper award in Osteoporosis' from the Spanish Society of Rheumatology. She is also member of the Editoral Board: Rheumatology of the journal BioMed Research International She has authored more than 60 research articles/books. She is a Member of the 'Scientific Committee of the Spanish Registry for Adverse Events Related to Biological Therapies in Rheumatic Diseases', of the 'Spanish working group on Pharmacovigilance', of the 'Faculty of Physicians of the University of Barcelona' and also of the 'Spanish Society of Rheumatology'

Research Interest

The safety and efficacy of biological therapies in patients with rheumatic inflammatory conditions, and also in patients with non-infectious uveitis. She has also conducted several clinical trials in patients with rheumatoid arthritis and spondyloarthritis.